Advertisement

Drugs & Therapy Perspectives

, Volume 34, Issue 8, pp 372–376 | Cite as

Antipsychotic drugs may increase the risk of venous thromboembolism

  • Adis Medical Writers
Drug Reactions and Interactions
  • 81 Downloads

Abstract

A wide range of observational studies have demonstrated an increased risk of venous thromboembolism (VTE) in patients receiving antipsychotic drugs. Although current data cannot conclusively verify differences in VTE occurrence rates between individual antipsychotic drugs or different generations thereof, information is sufficient to warrant an increased awareness of this potentially serious adverse drug reaction, as well as consideration of prophylactic antithrombotic therapy in at-risk patients.

Notes

Compliance with ethical standards

Funding

The preparation of this review was not supported by any external funding.

Conflict of interest

The article was adapted from CNS Drugs 2018;32(1):47–64 [4] by employees of Adis/Springer, who are responsible for the article content and declare no conflicts of interest.

References

  1. 1.
    Beckman MG, Hooper WC, Critchley SE, et al. Venous thromboembolism: a public health concern. Am J Prev Med. 2010;38(4 Suppl):S495–501.CrossRefGoogle Scholar
  2. 2.
    Raskob GE, Angchaisuksiri P, Blanco AN, et al. Thrombosis: a major contributor to the global disease burden. J Thromb Haemost. 2014;12(10):1580–90.CrossRefGoogle Scholar
  3. 3.
    Wells P, Anderson D. The diagnosis and treatment of venous thromboembolism. Hematol Am Soc Hematol Educ Program. 2013;2013:457–63.CrossRefGoogle Scholar
  4. 4.
    Jönsson AK, Schill J, Olsson H, et al. Venous thromboembolism during treatment with antipsychotics: a review of current evidence. CNS Drugs. 2018;32(1):47–64.CrossRefGoogle Scholar
  5. 5.
    Lacut K, Le Gal G, Couturaud F, et al. Association between antipsychotic drugs, antidepressant drugs and venous thromboembolism: results from the EDITH case–control study. Fundam Clin Pharmacol. 2007;21(6):643–50.CrossRefGoogle Scholar
  6. 6.
    Jönsson AK, Horvath-Puho E, Hagg S, et al. Antipsychotics and risk of venous thromboembolism: a population-based case–control study. Clin Epidemiol. 2009;1:19–26.CrossRefGoogle Scholar
  7. 7.
    Parker C, Coupland C, Hippisley-Cox J. Antipsychotic drugs and risk of venous thromboembolism: nested case–control study. BMJ. 2010;341:c4245.CrossRefGoogle Scholar
  8. 8.
    Ishiguro C, Wang X, Li L, et al. Antipsychotic drugs and risk of idiopathic venous thromboembolism: a nested case–control study using the CPRD. Pharmacoepidemiol Drug Saf. 2014;23(11):1168–75.CrossRefGoogle Scholar
  9. 9.
    Wu CS, Lin CC, Chang CM, et al. Antipsychotic treatment and the occurrence of venous thromboembolism: a 10-year nationwide registry study. J Clin Psychiatry. 2013;74(9):918–24.CrossRefGoogle Scholar
  10. 10.
    Wang MT, Liou JT, Huang YW, et al. Use of antipsychotics and risk of venous thromboembolism in postmenopausal women: a population-based nested case–control study. Thromb Haemost. 2016;115(6):1209–19.CrossRefGoogle Scholar
  11. 11.
    Conti V, Venegoni M, Cocci A, et al. Antipsychotic drug exposure and risk of pulmonary embolism: a population-based, nested case–control study. BMC Psychiatry. 2015;15:92.CrossRefGoogle Scholar
  12. 12.
    Kleijer BC, Heerdink ER, Egberts TC, et al. Antipsychotic drug use and the risk of venous thromboembolism in elderly patients. J Clin Psychopharmacol. 2010;30(5):526–30.CrossRefGoogle Scholar
  13. 13.
    Schmedt N, Garbe E. Antipsychotic drug use and the risk of venous thromboembolism in elderly patients with dementia. J Clin Psychopharmacol. 2013;33(6):753–8.CrossRefGoogle Scholar
  14. 14.
    Allenet B, Schmidlin S, Genty C, et al. Antipsychotic drugs and risk of pulmonary embolism. Pharmacoepidemiol Drug Saf. 2012;21(1):42–8.CrossRefGoogle Scholar
  15. 15.
    Hsu WY, Lane HY, Lin CL, et al. A population-based cohort study on deep vein thrombosis and pulmonary embolism among schizophrenia patients. Schizophr Res. 2015;162(1–3):248–52.CrossRefGoogle Scholar
  16. 16.
    Ferraris A, Szmulewicz AG, Vazquez FJ, et al. Antipsychotic use among adult outpatients and venous thromboembolic disease: a retrospective cohort study. J Clin Psychopharmacol. 2017;37(4):405–11.CrossRefGoogle Scholar
  17. 17.
    Hippisley-Cox J, Coupland C. Development and validation of risk prediction algorithm (QThrombosis) to estimate future risk of venous thromboembolism: prospective cohort study. BMJ. 2011;343:d4656.CrossRefGoogle Scholar
  18. 18.
    Nakamura M, Yamada N, Oda E, et al. Predictors of venous thromboembolism recurrence and the bleeding events identified using a Japanese healthcare database. J Cardiol. 2017;70(2):155–62.CrossRefGoogle Scholar
  19. 19.
    Ray JG, Mamdani MM, Yeo EL. Antipsychotic and antidepressant drug use in the elderly and the risk of venous thromboembolism. Thromb Haemost. 2002;88(2):205–9.PubMedGoogle Scholar
  20. 20.
    Liperoti R, Pedone C, Lapane KL, et al. Venous thromboembolism among elderly patients treated with atypical and conventional antipsychotic agents. Arch Intern Med. 2005;165(22):2677–82.CrossRefGoogle Scholar
  21. 21.
    Dennis M, Shine L, John A, et al. Risk of adverse outcomes for older people with dementia prescribed antipsychotic medication: a population based e-cohort study. Neurol Ther. 2017;6(1):57–77.CrossRefGoogle Scholar
  22. 22.
    Letmaier M, Grohmann R, Kren C, et al. Venous thromboembolism during treatment with antipsychotics: results of a drug surveillance programme. World J Biol Psychiatry. 2018;19(3):175–86.CrossRefGoogle Scholar
  23. 23.
    Hägg S, Bate A, Stahl M, et al. Associations between venous thromboembolism and antipsychotics: a study of the WHO database of adverse drug reactions. Drug Saf. 2008;31(8):685–94.CrossRefGoogle Scholar
  24. 24.
    Hägg S, Spigset O, Söderström TG. Association of venous thromboembolism and clozapine. Lancet. 2000;355(9210):1155–6.CrossRefGoogle Scholar
  25. 25.
    Barbui C, Conti V, Cipriani A. Antipsychotic drug exposure and risk of venous thromboembolism: a systematic review and meta-analysis of observational studies. Drug Saf. 2014;37(2):79–90.CrossRefGoogle Scholar
  26. 26.
    Zhang R, Dong L, Shao F, et al. Antipsychotics and venous thromboembolism risk: a meta-analysis. Pharmacopsychiatry. 2011;44(5):183–8.CrossRefGoogle Scholar
  27. 27.
    Malý R, Masopust J, Hosak L, et al. Assessment of risk of venous thromboembolism and its possible prevention in psychiatric patients. Psychiatry Clin Neurosci. 2008;62(1):3–8.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.SpringerAucklandNew Zealand

Personalised recommendations